We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Compound Triggers Myelin Repair in Mouse Model of MS

News   Apr 24, 2019 | Original story from OHSU

 
Compound Triggers Myelin Repair in Mouse Model of MS

Tom Scanlan, Ph.D. (left) reviews material with Meredith D. Hartley, Ph.D. Scanlan developed sobetirome as a synthetic molecule intended to lower cholesterol, but in recent years adapted it as a promising treatment for a rare metabolic disease called adrenoleukodystrophy, or ALD. Credit: OHSU/Kristyna Wentz-Graff

 
 
 

RELATED ARTICLES

Assessment Changes Open Up Neuroscience Research to People With Intellectual Disabilities

News

Adaptations to the NIH cognitive function assessment could ensure that the battery can be used to assess the cognitive ability of people with intellectual disabilities, providing objective measures that could be used in a wide variety of studies.

READ MORE

What Makes a Monkey Drink Alone?

News

Researchers have uncovered a unique signature of neural synchrony that reflects either a pro-social or an anti-social decision being made.

READ MORE

TMS Shows Promise for Treating Stroke and Migraine

News

A new literature review highlights the data supporting further studies into the use of transcranial magnetic stimulation (TMS) to treat a broader range of common neurological conditions, including stroke and migraine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE